Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L35a pseudogene 23 (RPL35AP23) is a human pseudogene—a genomic DNA sequence similar to the functional ribosomal protein L35a gene, but it is non-coding and incapable of producing a functional protein product. This pseudogene is catalogued in genomic databases and may be transcribed, but studied evidence suggests it does not generate a functional ribosomal protein and is not implicated in protein synthesis or direct pathogenesis. It is not considered a therapeutic target, does not interact with drugs, and is not associated with adverse events or clinical relevance in the context of molecular targeting for disease.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35a pseudogene 23 (RPL35AP23).